CVR Medical Corp

Healthcare US CRRVF

0.0USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

52 Week Range

-0.0099

LowHigh

Fundamentals

Previous Close -
Market Cap0.02M
Volume0
P/E Ratio-
Dividend Yield-%
EBITDA-0.52015M
Revenue TTM0.00000M
Revenue Per Share TTM-
Gross Profit TTM 0.00000M
Diluted EPS TTM-0.03

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Income before tax	-1.81762M	-0.17340M	-5.13713M	-7.44193M	-6.75464M
Minority interest	-	-	-	-	0.00000M
Net income	-1.81762M	-0.17340M	-5.13713M	-7.44193M	-6.75464M
Selling general administrative	0.56M	0.02M	2.90M	4.46M	2.16M
Selling and marketing expenses	-	-	-	-	-
Gross profit	-	-	-	-	0.00000M
Reconciled depreciation	0.00025M	0.00023M	0.00023M	0.00024M	0.00022M
Ebit	-0.59478M	-0.08737M	-4.97985M	-6.45588M	-3.88794M
Ebitda	-0.59453M	-0.08714M	-4.97961M	-6.45564M	-5.12320M
Depreciation and amortization	0.00025M	0.00023M	0.00023M	0.00024M	-
Non operating income net other	-	-	-	-	-
Operating income	-0.59478M	-0.08737M	-4.97985M	-6.45588M	-5.12320M
Other operating expenses	0.59M	0.08M	4.98M	6.45M	5.13M
Interest expense	0.07M	0.07M	0.09M	0.16M	0.00040M
Tax provision	-	-	-	-	-
Interest income	-	0.00000M	0.00769M	0.00000M	0.00769M
Net interest income	-0.07440M	-0.07637M	-0.09224M	-0.16323M	0.00729M
Extraordinary items	-	-	-	-	0.00000M
Non recurring	-	-	-	-	0.00000M
Other items	-	-	-	-	0.00000M
Income tax expense	0.07M	0.07M	0.09M	0.16M	0.00000M
Total revenue	0.00000M	0.00000M	0.00000M	0.00000M	0.00000M
Total operating expenses	0.59M	0.08M	4.98M	6.45M	5.13M
Cost of revenue	-	-	-	-	0.00000M
Total other income expense net	-1.14998M	-0.01207M	-0.06231M	-0.82658M	-1.63144M
Discontinued operations	-	-	-	-	0.00000M
Net income from continuing ops	-1.81762M	-0.17340M	-5.13713M	-7.44193M	-6.75464M
Net income applicable to common shares	-1.81762M	-0.17340M	-5.13713M	-7.44193M	-6.55224M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Total assets	0.10M	1.22M	1.21M	1.38M	1.72M
Intangible assets	0.00000M	1.15M	-	1.08M	1.17M
Earning assets	-	-	-	-	-
Other current assets	-	-	-	-	0.02M
Total liab	4.55M	3.91M	3.43M	1.17M	0.11M
Total stockholder equity	-4.45579M	-2.68621M	-2.22276M	0.21M	1.61M
Deferred long term liab	-	-	-	-	0.00000M
Other current liab	2.52M	2.11M	2.66M	0.78M	0.10M
Common stock	25.44M	25.35M	25.35M	22.91M	17.40M
Capital stock	25.44M	25.35M	25.35M	22.91M	-
Retained earnings	-32.56832M	-30.75070M	-30.57730M	-25.44016M	-17.22634M
Other liab	0.25M	0.25M	-	-	0.00000M
Good will	-	-	-	-	0.00000M
Other assets	-	-	-	-	0.00000M
Cash	0.09M	0.00345M	0.00323M	0.07M	0.46M
Cash and equivalents	-	-	-	-	-
Total current liabilities	4.28M	3.56M	3.32M	1.17M	0.11M
Current deferred revenue	-	-	-	-	-
Net debt	0.68M	0.62M	0.14M	-0.04974M	-0.46343M
Short term debt	0.50M	0.28M	0.04M	0.03M	0.00000M
Short long term debt	0.50M	0.28M	0.04M	0.03M	0.00000M
Short long term debt total	0.77M	0.62M	0.15M	0.03M	-
Other stockholder equity	2.67M	2.71M	3.00M	2.74M	18.84M
Property plant equipment	0.00003M	0.00027M	0.00051M	0.00071M	0.00102M
Total current assets	0.10M	0.07M	0.08M	0.30M	0.55M
Long term investments	-	-	-	-	0.00000M
Net tangible assets	-4.45579M	-3.83898M	-3.35671M	-0.86597M	0.45M
Short term investments	-	-	-	-	0.00000M
Net receivables	0.00317M	0.01M	0.01M	0.16M	0.03M
Long term debt	0.27M	0.09M	0.11M	-	0.00000M
Inventory	-	-	-	-	0.00000M
Accounts payable	1.26M	1.18M	0.63M	0.37M	0.01M
Total permanent equity	-	-	-	-	0.00000M
Noncontrolling interest in consolidated entity	-	-	-	-	0.00000M
Temporary equity redeemable noncontrolling interests	-	-	-	-	0.00000M
Accumulated other comprehensive income	2.67M	2.71M	3.00M	2.74M	0.00000M
Additional paid in capital	-	-	-	-	0.00000M
Common stock total equity	-	-	-	-	0.00000M
Preferred stock total equity	-	-	-	-	0.00000M
Retained earnings total equity	-	-	-	-	0.00000M
Treasury stock	-	-	-	-	0.00000M
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	1.08M	1.17M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.00003M	1.15M	1.13M	1.08M	1.17M
Capital lease obligations	-	-	-	-	-
Long term debt total	-	-	-	-	-

Breakdown	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31
Investments	-	-	0.00000M	-0.80128M	-2.57653M
Change to liabilities	0.09M	0.49M	0.14M	0.40M	-0.04563M
Total cashflows from investing activities	-	-	-	-0.93194M	-2.57776M
Net borrowings	0.11M	0.18M	0.11M	0.03M	0.03M
Total cash from financing activities	0.20M	0.18M	2.13M	4.92M	7.03M
Change to operating activities	0.51M	-0.28775M	1.89M	0.67M	-0.10639M
Net income	-1.81762M	-0.17340M	-5.13713M	-7.44193M	-6.75464M
Change in cash	0.09M	0.00021M	-0.07151M	-0.38879M	0.27M
Begin period cash flow	0.00345M	0.00323M	0.07M	0.46M	0.10M
End period cash flow	0.09M	0.00345M	0.00323M	0.07M	0.27M
Total cash from operating activities	-0.08840M	-0.18043M	-2.08359M	-4.36136M	-6.75464M
Issuance of capital stock	0.09M	0.00000M	2.02M	4.03M	-
Depreciation	0.00025M	0.00023M	0.00023M	0.00024M	0.00021M
Other cashflows from investing activities	-	-	-	-0.13066M	-0.13066M
Dividends paid	-	-	-	-	0.00000M
Change to inventory	-	-	-	-	0.00000M
Change to account receivables	-	-	-	-	-0.00830M
Sale purchase of stock	-	0.00000M	-	-	3.72M
Other cashflows from financing activities	0.11M	-	0.11M	1.67M	-0.00123M
Change to netincome	1.12M	-0.20142M	0.88M	2.04M	2.84M
Capital expenditures	0.00000M	0.00000M	0.00000M	0.00000M	0.00123M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.61M	0.19M	2.17M	1.04M	-0.18641M
Stock based compensation	-0.04315M	-0.24763M	0.74M	1.24M	-
Other non cash items	1.16M	0.05M	0.14M	0.80M	6.75M
Free cash flow	-0.08840M	-0.18043M	-2.08359M	-4.36136M	-6.75587M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to EBITDA (x)
CRRVF CVR Medical Corp	- -%	-	-	-	-	12.60	-0.4651
ABT Abbott Laboratories	-0.58 0.66%	87.83	25.97	17.24	3.57	3.20	3.81	16.75
SYK Stryker Corporation	-3.11 1.01%	304.69	44.07	24.94	5.51	6.12	6.05	25.73
MDT Medtronic PLC	-0.07 0.09%	79.27	26.60	15.87	3.35	2.08	3.90	14.12
BSX Boston Scientific Corp	-0.96 2.12%	44.33	31.49	17.24	4.41	3.65	4.88	19.19

Reports Covered

View All

Profile

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.

CVR Medical Corp

221 West Esplanade, North Vancouver, BC, Canada, V7M 3J3

757-909-0491
https://www.cvrmed.com

Key Executives

Name	Title	Year Born
Dr. Paul S. Blunden M.D.	Pres, Director, Medical Advisor & CFO	NA
Mr. Philip Bendick Ph.D.	Medical Advisor & Independent Board Director	NA
Mr. Darren Day	Chief Exec. Officer	NA
Mr. Alan Langston	VP of Sales & Marketing	NA
Dr. Orville Day	Lead Physicist	NA
Mr. Erwin Wong B.Com.	Strategic Financial Consultant	1968
Mr. Jeremy Poirier	Consultant	1986

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.